We investigated here if the increased mammary cancer risk and epigenetic changes in in utero HF exposed animals are reversible by treating mice with the broad spectrum HDAC and DNMT inhibitors VPA and hydralazine, respectively. The gene discussed is HDAC9; the disease is breast cancer.